General Archive
-
Funding: LifeArc-CSO fund for Scottish translational researchers
Funding: LifeArc-CSO fund for Scottish translational researchers In association with the Chief Scientist Office (CSO) for the Scottish Government, we…
-
Funding: LifeArc gene therapy innovation fund
Funding: LifeArc gene therapy innovation fund The LifeArc Gene Therapy Innovation Fund is a £5m annual fund to support manufacture…
-
Funding: LifeArc and GOSH charity fund
Funding: LifeArc and GOSH charity fund LifeArc and GOSH Charity support a joint funding scheme focused on helping GOSH researchers…
-
Funding: LifeArc and Action Medical research fund
Funding: LifeArc and Action Medical research fund Action Medical Research and LifeArc want to improve the lives of children suffering…
-
LifeArc Philanthropic fund
Funding: LifeArc philanthropic fund The Fund provides grants and funding to academic researchers working to advance new treatments and diagnostics…
-
Funding: Repurposing therapies for epidermolysis bullosa (EB)
Funding: Repurposing therapies for epidermolysis bullosa (EB) LifeArc and DEBRA Austria are partnering to commit £2.5 million to fund projects…
-
Funding: Translational Rare Disease Centres
Funding: Translational Rare Disease Centres With this £40 million we aim to build on the UK’s rich, rare disease research…
-
Muscular Dystrophy Translational Research Fund
Muscular Dystrophy Translational Research Fund The Muscular Dystrophy Translational Research Fund is a joint fund created by LifeArc and Muscular…
-
News releasesLifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789
A pivotal clinical trial to look at repurposing the UK-licensed medicine, deferiprone, for patients with neuroferritinopathy, an ultra-rare genetic disease…
-
Articles & blogs6 challenges in rare disease research and how we can overcome them
Rare conditions, individually, have low patient numbers. However, with more than 7,000 rare diseases identified, collectively there are millions of…
-
Articles & blogsCatriona Crombie talks to Rare Revolution about LifeArc’s investment of more than £100 million into rare disease research by 2030
Catriona discusses why LifeArc is well placed to help overcome some of the obstacles in rare disease research
-
News releasesGroundbreaking new £100m LifeArc programme aims to improve the lives of people living with a rare disease
Brings together the world-leading expertise of Health Data Research UK, University of Edinburgh, LifeArc, Eisai and Gates Ventures